Primary literature |
Mullally MM, Meisel H, FitzGerald RJ. Synthetic peptides corresponding to alpha-lactalbumin and beta-lactoglobulin sequences with angiotensin-I-converting enzyme inhibitory activity. Biol Chem Hoppe Seyler. 1996 Apr;377(4):259-60.
|
Other literature(s) |
[1] Fitzgerald R J, Meisel H. Lactokinins: Whey protein‐derived ACE inhibitory peptides[J]. Molecular Nutrition (&) Food Research, 1999, 43(3):165. [2] Murray B A, Fitzgerald R J. Angiotensin converting enzyme inhibitory
peptides derived from food proteins: biochemistry, bioactivity and
production[J]. Current Pharmaceutical Design, 2007, 13(8):-. [3] Bösze Z. Bioactive Components of Milk[M]. Springer New York, 2008. [4] Meisel H. Overview on Milk Protein-derived Peptides[J]. International Dairy Journal, 1998, 8(5–6):363-373. [5] Ono
S, Hosokawa M, Miyashita K, et al. Inhibition properties of dipeptides
from salmon muscle hydrolysate on angiotensin I-converting enzyme[J].
International Journal of Food Science & Technology, 2006,
41(4):383–386. [6] Ap D L R, Montoya A B, MartãNez-Cuevas P, et al.
Tryptic amaranth glutelin digests induce endothelial nitric oxide
production through inhibition of ACE: antihypertensive role of amaranth
peptides[J]. Nitric Oxide, 2010, 23(2):106-111.
|
PubDate |
1996 |